226.17
1.03%
+2.30
Teleflex Incorporated stock is currently priced at $226.17, with a 24-hour trading volume of 288.95K.
It has seen a +1.03% increased in the last 24 hours and a +0.61% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $222.0 pivot point. If it approaches the $228.1 resistance level, significant changes may occur.
Teleflex Incorporated Stock (TFX) Financials Data
Teleflex Incorporated (TFX) Revenue 2023
TFX reported a revenue (TTM) of $2.97 billion for the quarter ending December 31, 2023, a +6.57% rise year-over-year.
Teleflex Incorporated (TFX) Net Income 2023
TFX net income (TTM) was $356.33 million for the quarter ending December 31, 2023, a -1.88% decrease year-over-year.
Teleflex Incorporated (TFX) Cash Flow 2023
TFX recorded a free cash flow (TTM) of $419.20 million for the quarter ending December 31, 2023, a +59.42% increase year-over-year.
Teleflex Incorporated (TFX) Earnings per Share 2023
TFX earnings per share (TTM) was $7.53 for the quarter ending December 31, 2023, a -1.95% decline year-over-year.
Teleflex Incorporated Stock (TFX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Hicks Cameron P | Corp. VP & Chief HR Officer |
Mar 05 '24 |
Option Exercise |
135.14 |
7,401 |
1,000,197 |
17,451 |
Hicks Cameron P | Corp. VP & Chief HR Officer |
Mar 05 '24 |
Sale |
225.00 |
7,401 |
1,665,225 |
10,050 |
Logue Daniel V. | CVP, General Counsel & Secty |
Feb 26 '24 |
Option Exercise |
101.12 |
1,525 |
154,208 |
12,278 |
Kelly Liam | Chairman, President & CEO |
Dec 27 '23 |
Option Exercise |
101.87 |
26,256 |
2,674,571 |
44,726 |
Kelly Liam | Chairman, President & CEO |
Dec 27 '23 |
Sale |
250.23 |
26,256 |
6,570,023 |
18,470 |
Klasko Stephen K. M.D. | Director |
Dec 13 '23 |
Option Exercise |
101.12 |
3,021 |
305,484 |
7,584 |
POWELL THOMAS E | Executive Vice President & CFO |
Nov 29 '23 |
Option Exercise |
121.67 |
13,952 |
1,697,603 |
28,336 |
POWELL THOMAS E | Executive Vice President & CFO |
Nov 29 '23 |
Sale |
222.88 |
13,952 |
3,109,671 |
14,384 |
RANDLE STUART A | Director |
May 10 '23 |
Option Exercise |
101.12 |
3,021 |
305,484 |
7,868 |
RANDLE STUART A | Director |
May 10 '23 |
Sale |
245.71 |
3,021 |
742,290 |
4,847 |
Teleflex Incorporated Stock (TFX) Latest News
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
GlobeNewswire Inc.
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?
Zacks Investment Research
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Zacks Investment Research
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
Zacks Investment Research
Breaking Down Teleflex: 4 Analysts Share Their Views
Benzinga
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Zacks Investment Research
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Cap:
|
Volume (24h):